Empting, Martin
Helmholtz Institute for Pharmaceutical Research Saarland · Saarland University
4 papers on CoChatORCID 0000-0002-0503-5830
Most cited papers
- Verified
Camelid and shark single domain antibodies: Structural features and therapeutic potential
Könning, D., Zielonka, S., Grzeschik, J., Empting, M., Valldorf, B., Krah, S., Schröter, C., Sellmann, C., Hock, B., & Kolmar, H. (2017) · Current Opinion in Structural Biology
Monoclonal and Polyclonal Antibodies ResearchProtein purification and stability
Cited by 214
- Verified
First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy
Dahlem, C., Abuhaliema, A., Kessler, S. M., Kröhler, T., Zoller, B. G. E., Chanda, S., Wu, Y., Both, S., Müller, F., Lepikhov, K., et al. (2022) · ACS Chemical Biology
RNA Research and SplicingCancer Mechanisms and Therapy
Cited by 70
- Verified
Aspherical and Spherical InvA497-Functionalized Nanocarriers for Intracellular Delivery of Anti-Infective Agents
Castoldi, A., Empting, M., De Rossi, C., Mayr, K., Dersch, P., Hartmann, R., Müller, R., Gordon, S., & Lehr, C.-M. (2019) · Pharmaceutical Research
Nanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery
Cited by 22
- Verified
Gene Editing and Small Molecule Inhibitors of the RNA Binding Protein IGF2BP2/IMP2 Show its Potential as an Anti-Cancer Drug Target
Chanda, S., Lepikhov, K., Dahlem, C., Schymik, H. S., Hoppstädter, J., Geber, A.-K., Wagner, K., Kessler, S. M., Empting, M., & Kiemer, A. K. (2024) · Frontiers in Bioscience-Landmark
RNA Research and SplicingRNA regulation and disease
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free